Batterson Venture Capital
5
4M
4
0.71
0.20
2
- Stages of investment
- Areas of investment
Summary
The leading representative office of defined VC is situated in the Chicago. The venture was found in North America in United States.
We can highlight the next thriving fund investment areas, such as Biopharma, Enterprise. Among the most popular portfolio startups of the fund, we may highlight Cleversafe, Intensity Therapeutics, Octave Communications. For fund there is a match between the location of its establishment and the land of its numerous investments - United States. The fund has exact preference in a number of founders of portfolio startups. Moreover, a startup needs to be at the age of 4-5 years to get the investment from the fund.
The standard case for the fund is to invest in rounds with 3-4 partakers. Despite the Batterson Venture Capital, startups are often financed by OCA Ventures, New Enterprise Associates, Alsop Louie Partners. The meaningful sponsors for the fund in investment in the same round are VCapital, St. Paul Venture Capital, SalvaRx Group PLC. In the next rounds fund is usually obtained by St. Paul Venture Capital, New Enterprise Associates, Bessemer Venture Partners.
The current fund was established by Len Batterson.
The important activity for fund was in 2007. The common things for fund are deals in the range of 5 - 10 millions dollars. The fund is constantly included in less than 2 deals per year. The real fund results show that this VC is 0 percentage points less often commits exit comparing to other companies. The top amount of exits for fund were in 2015. Opposing the other organizations, this Batterson Venture Capital works on 11 percentage points more the average amount of lead investments.
Investments analytics
Analytics
- Total investments
- 5
- Lead investments
- 0
- Exits
- 2
- Rounds per year
- 0.71
- Follow on index
- 0.20
- Investments by industry
- Data Storage (2)
- Enterprise (2)
- Software (2)
- Video Conferencing (1)
- Audio (1) Show 6 more
- Investments by region
-
- United States (5)
- Peak activity year
- 2009
- Number of Unicorns
- 1
- Number of Decacorns
- 1
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 14
- Avg. valuation at time of investment
- 352M
- Group Appearance index
- 0.80
- Avg. company exit year
- 8
- Avg. multiplicator
- 10.33
- Strategy success index
- 0.20
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
Company name | Deal date | Industry | Deal stage | Deal size | Location |
---|---|---|---|---|---|
Intensity Therapeutics | 28 Jun 2016 | Biotechnology, Therapeutics, Biopharma | Early Stage Venture | 10M | United States, Connecticut, Norwalk |
Similar funds
By same location
By same geo focus
By doing lead investments
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.